
Sterling G. West
M.D.
Professor of Medicine
Medical School: Emory University School of Medicine, Atlanta, Georgia
Postgraduate training:
| 1976-1979 | Internship/Residency | Internal Medicine, Fitzsimons Army Medical Center Aurora, Colorado |
| 1979-1981 | Fellowship | Rheumatology, Walter Reed Army Medical Center Washington, D.C. |
When arrived at UCD: 1995
Past and current professional positions:
| 1981-1995 | Chief, Rheumatology | Department of Internal Medicine, Fitzsimons Army Medical Center, Aurora, CO |
| 1983-1986 | Clinical Instructor | Department of Internal Medicine, Division of Rheumatology University of Colorado Denver |
| 1986-1990 | Assistant Clinical Professor | Department of Internal Medicine, Division of Rheumatology University of Colorado Denver |
| 1990-1995 | Associate Clinical Professor | Department of Internal Medicine, Division of Rheumatology University of Colorado Denver |
| 1995-1998 | Clinical Director | Autoimmune Disease Center, National Jewish Medical and Research Center, Denver, CO |
| 1995-Present | Professor, Rheumatology Fellowship Training Program Director | Department of Internal Medicine, Division of Rheumatology University of Colorado Denver |
| 1998-Present | Co Director | Metabolic Bone Disease Center, University of Colorado Denver |
National commitments, positions:
| Member | ABIM Subspecialty Board on Rheumatology |
| Member | ACR Committee on Rheumatology Training and Workforce Issues |
Awards and Honors received:
| AMSUS Phillip Hench Award | |
| Order of Military Medical Merit | |
| Outstanding Staff Teacher Award | |
| UCD Clinical Faculty Research Award | |
| Laureate Award American College of Physicians | |
| The Best Doctors in America Award | |
| Denver's Top Doctors Award | |
| ACR Clinical Scholar Educator Award | |
| Master, American College of Physicians |
Description of research interests and/or clinical trial interests:
Major area of research interest is in the pathophysiology and treatment of neuropsychiatric lupus. Clinical research trial currently ongoing is measuring cognitive dysfunction and depression in SLE patients and correlating symptoms with MRI and MR spectroscopy abnormalities. Additional areas of interest are metabolic bone disease and clinical trials.
Representative publications: